Circulation · 2009 · 106 citations · 36 references
We demonstrate directly and for the first time that endothelial ERalpha represents a key target of the atheroprotective effect of estradiol, whereas hematopoietic ERalpha is dispensable. Selective estrogen receptor modulators that mimic the endothelial action of estradiol should now be considered in atheroprotection.
36
Dennis B. Lubahn, Jeffrey S. Moyer, T S Golding et al. · Proceedings of the National Academy of Sciences · 1993 · 1.8K citations · Full text
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
Jacques E. Rossouw, Ross L. Prentice, JoAnn E. Manson et al. · JAMA · 2007 · 1.7K citations · Full text